Fast Company Impact Council
Responsible compounding could close the innovation gap
Especially in women’s health, this former regulatory gray area could help patients who have waited too long for FDA-approved solutions. You’ve probably seen compounding making headlines recently, and not for the right reasons. From so-called “personalized” GLP-1s flooding the market to telehealth s...
3080 views
